Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study

Open access
Madrid, Antonio H, Ortega, Javier, Rebollo, Jose G, Manzano, Juan G, Segovia, Javier G, Sánchez, Andrés, Peña, Gonzalo, Moro, Concepción · 2001 · Journal of the American College of Cardiology

Abstract

Objectives This study was designed to evaluate the efficacy of atenolol for the long-term management of patients with vasovagal syncope. The primary hypothesis was that atenolol is not superior to placebo for the treatment of vasovagal syncope. Background There is no definitive well-controlled analysis of the efficacy of beta-adrenergic blocking agents in patients with recurrent vasovagal syncope. Methods This is a prospective, randomized, double-blind, placebo-controlled study. Fifty patients with recurrent vasovagal syncope were included (at least two episodes in the last year). A baseline tilt test was performed. Twenty patients (40%) had a positive tilt test. Intravenous atenolol prevented a second positive tilt in five patients. The patients were randomized to receive either atenolol or a placebo (26 patients atenolol 50 mg/day, 24 patients placebo). The follow-up procedure lasted one year. The primary end point of the study was the time to first recurrence of syncope. Results In the intention-to-treat analysis, the group treated with atenolol had a similar number of patients with recurrent syncopal episodes as the placebo group. The Kaplan-Meier actuarial estimates of time to first syncopal recurrence showed that the probability of remaining free of syncope drops similarly in both groups and that there was no statistical difference between both curves (patients treated with atenolol vs. the placebo) with a log-rank test p value of 0.4517. Conclusions The recurrence of n…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(00)01155-4

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 2

  1. Brignole, 1999, Dual-chamber pacing is efficacious in treatment of neurally-mediated tilt positive cardioinhibitory syncope; pacemaker versus no therapy, Circulation, 100, 3387
  2. Fitzpatrick, 1991, A randomized trial of medical therapy in “malignant vasovagal syndrome or neurally-mediated bradycardia/hypotension syndrome”, Eur J Cardiac Pacing Electrophysiol, 2, 99

Cited by

See all 206

Metadata

Authors
Madrid, A. H., Ortega, J., Rebollo, J. G., Manzano, J. G., Segovia, J. G., Sánchez, A., Peña, G., & Moro, C.
Affiliations
Hospital Universitario Ramón y Cajal (ES)
Corresponding author
Moro, Concepción
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2001-02
Volume
37
Issue
2
Pages
554-559
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2167029785
Cited by
205
References
37
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 8 · 2014: 2 · 2013: 9 · 2012: 8
FWCI
16.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
Keywords
atenolol, neurally mediated syncope, vasovagal syncope, beta-blockers, syncope recurrence, tilt table test
MeSH terms
Adolescent, Adrenergic beta-Antagonists, Adult, Aged, Atenolol, Double-Blind Method, Female, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Treatment Failure, Tilt-Table Test, Syncope, Vasovagal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. https://app.cochat.ai/papers/10.1016/s0735-1097(00)01155-4
The paper
Madrid, A. H., Ortega, J., Rebollo, J. G., Manzano, J. G., Segovia, J. G., Sánchez, A., Peña, G., & Moro, C. (2001). Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(00)01155-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.